Moolec Science (MLEC) Receivables (2022 - 2025)
Moolec Science (MLEC) reported Receivables of $19.9 million for Q2 2025, down 91.82% on a YoY basis from $243.7 million in Q2 2024, and up 627.91% sequentially from $2.7 million in Q4 2024.
Moolec Science (MLEC) Receivables (2022 - 2025) Analysis & Trends
Moolec Science (MLEC) has 4 years of Receivables data on file, last reported at $19.9 million in Q2 2025.
- For the quarter ending Q2 2025, Receivables fell 91.82% year-over-year to $19.9 million; the trailing twelve-month figure through Jun 2025 stood at $19.9 million (down 91.82% YoY), and the FY2025 full-year result was $19.9 million, down 91.82% from the prior year.
- Receivables advanced to $19.9 million in Q2 2025, from $2.7 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $243.7 million in Q2 2024 to a low of $4122.0 in Q2 2022.
- A 4-year average of $28.3 million and a median of $1.8 million in 2023 frame the typical range for Receivables.
- Across the five-year window, Receivables soared 221251.87% in 2023 and sank 91.82% in 2025, its largest moves.
- Tracing MLEC's Receivables over 4 years: stood at $4122.0 in 2022, then surged by 29018.83% to $1.2 million in 2023, then soared by 128.16% to $2.7 million in 2024, then surged by 627.91% to $19.9 million in 2025.
- Business Quant data shows MLEC's Receivables at $19.9 million in Q2 2025, $2.7 million in Q4 2024, and $1.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | - |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 19.93 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 243.66 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 9.12 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Jun 30, 2022 | 4,122.00 |